Akers bioscience plc share price

Jul 13, 2018 · Revenue from the Company’s PIFA Heparin/PF4 Rapid Assay products decreased 54% to $259,983 (2017: $560,921) during the three months ended March 31, 2018, over the same period of 2017. AKER Stock Quote of Akers Biosciences - InvestorPlace Check out our AKER stock analysis, current AKER quote, charts, and historical prices for Akers Biosciences stock

Akers Biosciences, Inc. develops health information technologies. It engages in the developing, manufacturing, and supplying screening and testing products to deliver healthcare information to consumers and healthcare providers. Its products include clinical diagnostics, safety diagnostics, wellness products, and tests in development. The company was founded by Raymond Francis Akers, … Akers Company Overview Biosciences, Inc. NasdaqCM: AKER ... We are valuing Akers using a P/S multiple of 5.0x. We apply this multiple to our FY15 estimated revenue per share projection of $2.77 and derive a target price of $13.85. Investment Highlights Over 125% revenue increase in 2013; anticipating sales growth and margin improvement going forward Akers Biosciences, Inc. (AKER) Stock Analysis & News ... Get breaking news and analysis on Akers Biosciences, Inc. (AKER) stock, price quote and chart, trading and investing tools. Akers Biosciences Inc Stock Technical Analysis (AKER ... Detailed technical analysis and trading signals for the Akers Biosciences Inc Stock. share your perspective and ask questions of authors and each other. The higher ups don't want a bunch

The share data supplied on this page is provided by AJ Bell Media and incorporates share prices, market news, indices, charts, fundamentals, heatmaps, stock screeners and investor research tools. AJ Bell Media Terms & Conditions.

Akers Biosciences Inc Shares Outstanding 2012-2019 | AKER ... Akers Biosciences Inc shares outstanding from 2012 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares. Akers Biosciences (AKER) Stock Price History | wallmine Akers Biosciences, Inc. develops health information technologies. It engages in the developing, manufacturing, and supplying screening and testing products to deliver healthcare information to consumers and healthcare providers. Its products include clinical diagnostics, safety diagnostics, wellness products, and tests in development. The company was founded by Raymond Francis Akers, … Akers Company Overview Biosciences, Inc. NasdaqCM: AKER ... We are valuing Akers using a P/S multiple of 5.0x. We apply this multiple to our FY15 estimated revenue per share projection of $2.77 and derive a target price of $13.85. Investment Highlights Over 125% revenue increase in 2013; anticipating sales growth and margin improvement going forward

Real-time trade and investing ideas on Akers Biosciences Inc. AKER from the largest community of traders and investors.

Akers Biosciences Inc (AKR). 55.0p 0.00 (0.00 %). 28 Mar 2019, 16:57 · NB: This symbol is no longer being updated. Find out how to deal online from £1.50 in a  Mar 25, 2020 The price of the stock the last time has raised by 52.90% from its 52-Week high price while it is -91.56% than its 52-Week low price. A look at the 

1 day ago The last few days have been benevolent to the share price as AKER jumped by 120.19% during the last week, even though the stock is still up by 

Apr 30, 2019 · Akers Biosciences, Inc. (LON:AKR) Share Price and News. Akers Biosciences, Inc. develops, manufactures, and distributes rapid, point-of-care screening and testing products designed to … AKERS BIOSCIENCES INC Share Price - AKER Share Price There is much evidence that small caps, on average, outperform large caps over the long term, though in recent decades this has become more disputed.Many academic papers have shown that micro-caps, the very smallest companies, tend to be priced like ‘Lottery Tickets’ and have negative aggregate returns. AKER Akers Biosciences, Inc. Stock Quote Akers Biosciences, Inc., together with its subsidiaries, develops, produces, and sells rapid screening and testing products designed to deliver medical devices to healthcare providers and consumers in the United States, the People's Republic of China, and internationally. Akers Biosciences Inc (LSE:AKR) - Share price | AJ Bell ... Mar 28, 2019 · Akers Biosciences Inc,AKR,ISIN: US00973E3009 - view the latest price,charts and performance information at AJ Bell Youinvest. Skip to main content. Akers Biosciences Inc (LSE:AKR) - Share price. Home Market Research Akers Biosciences Inc (LSE:AKR) - Share price.

AKER | Akers Biosciences Inc. Annual Income Statement ...

This page features the latest news about the Akers Biosciences share. U.S. shares lower at close of trade; Dow Jones Industrial Average down 1.56% By Investing.com - Nov 19, 2018 Investing.com – U.S. equities were lower at the close on Monday, as losses in the Technology, Consumer Services and Industrials sectors propelled shares lower.

Akers Biosciences, Inc. (AKER) Stock Analysis & News ...